Year-end Unaudited but Review Audited 30 September 2019 31 March 2019 Net Profit (Loss) Indian Rupee (43,007,441) (65,497,534) Net Profit (Loss) per share Indian Rupee (1.36) (2.07) 5. Opinion of the
. International sales revenue dropped by 6.20 % compared to the last quarter, since the China and Philippines has endured more drastic impact from COVID-19, making the sales deviate from the original plan of the
23.6% YoY to THB 343mn Full-quarter recognition of ‘International Advertising’ Recognised net loss from non-recurring expenses of THB 180mn from impairment of assets, loss on disposal/ write-off of
equivalent to 113.30% because the Company re-estimates the performance, so the Company can use the deficit lower than the last year. Net profit (loss) For the 6 months period (quarter 2/2017), the Company has
year by Baht 9.23million or equivalent to 106.58 % because the Company re-estimates the performance, so the Company can use the deficit lower than the last year. Net profit (loss) For the 9 months period
medical services 121.38 117.29 104.77 4.08 3.48 16.60 15.85 340.79 286.49 54.29 18.95 Cost of services 112.06 107.97 100.54 4.09 3.79 11.52 11.46 319.63 289.14 30.49 10.55 Gross profit (loss) 9.31 9.33 4.23
2019: The separate financial statement for second quarter, 3 months period ended 30 June 2019, indicates that the net loss is 0.15 million baht which reduced from the same period of the previous years
continued focus on maximising delivery and retail sales. These actions, along with careful management of all costs and expenses, resulted in the company making a net profit in the first quarter of 2021 of THB
Profit (Loss) (82.53) 90.67 (173.20) (191.02) Earnings per share (Baht per share) (0.02) 0.02 (0.04) (200.00) Net Profit The company and subsidiaries realized net loss as of the fiscal year 2015, ended as
Costs - - 9.35 72.09 Administrative expenses, impairment finance costs and share of loss from associates 28.78 484.51 15.59 120.20 Management benefit expenses 5.21 87.71 5.78 44.56 Profit (Loss) before